Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Tundra lists 1 Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC) clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06784193

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

This is a first-in-human, open-label, multicenter phase 1 study to evaluate safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of OP-3136, a lysine acetyltransferases 6A and 6B (KAT6A/B) inhibitor, as monotherapy and in combination with other anticancer agents in participants with advanced solid tumors. This study consists of 2 parts: a dose escalation part (Part 1) and dose expansion part (Part 2).

Gender: All

Ages: 18 Years - Any

Updated: 2025-10-10

8 states

Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)

Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)